FLN29 Deficiency Reveals Its Negative Regulatory Role in the Toll-like Receptor (TLR) and Retinoic Acid-inducible Gene I (RIG-I)-like Helicase Signaling Pathway
Open accessThe DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Abstract
FLN29 was identified as an interferon (IFN)-inducible gene, and it has been shown to suppress Toll-like receptor 4-mediated NF-kappaB activation by binding to TRAF6. To elucidate the physiological roles of FLN29, we generated FLN29-deficient mice. FLN29 deficiency resulted in hyper-response to LPS both in vivo and in vitro, demonstrating the negative regulatory role of FLN29 in TLR4 signaling. Furthermore, we found that FLN29(-/-) mice exhibited increased susceptibility to poly(I:C)-induced septic shock compared with WT mice. FLN29(-/-) fibroblasts were highly resistant to vesicular stomatitis virus infection, and these cells produced more IFN-beta than WT cells did in response to not only intracellular poly(I:C) but also overexpression of IPS-1. Forced expression of FLN29 inhibited the IPS-1-dependent activation of both NF-kappaB and IRF3. We also found that FLN29 could interact with TRIF, IPS-1, TRAF3, and TRAF6. Together, these results suggest that FLN29, in addition to playing a negative regulatory role in the TLR4 signaling pathway, negatively regulates the RIG-I-like helicase signaling pathway at the level of IPS-1/TRAF6 and IPS-1/TRAF3 complexes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, transient up-regulation of the mRNA encoding the negative immune regulator Trafd1 (34) (Fig. 3F) is the main cause of a strong increase in its protein.”
From Dynamic profiling of the protein life cycle in response to pathogens (2015) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S., & Fujita, T. (2004) · Nature Immunology · doi:10.1038/ni1087 · Cited by 3,929
Seth, R. B., Sun, L., Ea, C.-K., & Chen, Z. J. (2005) · Cell · doi:10.1016/j.cell.2005.08.012 · Cited by 3,329
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K. J., Takeuchi, O., & Akira, S. (2005) · Nature Immunology · doi:10.1038/ni1243 · Cited by 2,562
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R., & Tschopp, J. (2005) · Nature · doi:10.1038/nature04193 · Cited by 2,401
VISA Is an Adapter Protein Required for Virus-Triggered IFN-β Signaling
Xu, L.-G., Wang, Y.-Y., Han, K.-J., Li, L.-Y., Zhai, Z., & Shu, H.-B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.08.014 · Cited by 1,853
SOCS proteins, cytokine signalling and immune regulation
Yoshimura, A., Naka, T., & Kubo, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2093 · Cited by 1,580
Self-citationSato, M., Suemori, H., Hata, N., Asagiri, M., Ogasawara, K., Nakao, K., Nakaya, T., Katsuki, M., Noguchi, S., Tanaka, N., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00053-4 · Cited by 1,339
IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling
Kobayashi, K., Hernandez, L. D., Galán, J. E., Janeway, C. A., Medzhitov, R., & Flavell, R. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00827-9 · Cited by 1,286
Gitlin, L., Barchet, W., Gilfillan, S., Cella, M., Beutler, B., Flavell, R. A., Diamond, M. S., & Colonna, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603082103 · Cited by 1,169
The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses
Boone, D. L., Turer, E. E., Lee, E. G., Ahmad, R.-C., Wheeler, M. T., Tsui, C., Hurley, P., Chien, M., Chai, S., Hitotsumatsu, O., et al. (2004) · Nature Immunology · doi:10.1038/ni1110 · Cited by 1,090
SOCS1/JAB Is a Negative Regulator of LPS-Induced Macrophage Activation
Kinjyo, I., Hanada, T., Inagaki-Ohara, K., Mori, H., Aki, D., Ohishi, M., Yoshida, H., Kubo, M., & Yoshimura, A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00446-6 · Cited by 630
Self-citationA system for functional analysis of Ebola virus glycoprotein
Takada, A., Robison, C., Goto, H., Sanchez, A., Murti, K. G., Whitt, M. A., & Kawaoka, Y. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14764 · Cited by 575
Lenardo, M. J., Fan, C.-M., Maniatis, T., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90966-5 · Cited by 473
Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125
Arimoto, K.-I., Takahashi, H., Hishiki, T., Konishi, H., Fujita, T., & Shimotohno, K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611551104 · Cited by 472
A Deubiquitinase That Regulates Type I Interferon Production
Kayagaki, N., Phung, Q., Chan, S., Chaudhari, R., Quan, C., O'Rourke, K. M., Eby, M., Pietras, E., Cheng, G., Bazan, J. F., et al. (2007) · Science · doi:10.1126/science.1145918 · Cited by 452
Recognition of viruses by innate immunity
Takeuchi, O., & Akira, S. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00562.x · Cited by 342
The tumour suppressor CYLD is a negative regulator of RIG‐I‐mediated antiviral response
Friedman, C. S., O'Donnell, M. A., Legarda‐Addison, D., Ng, A., Cárdenas, W. B., Yount, J. S., Moran, T. M., Basler, C. F., Komuro, A., Horvath, C. M., et al. (2008) · EMBO reports · doi:10.1038/embor.2008.136 · Cited by 334
TRADD Protein Is an Essential Component of the RIG-like Helicase Antiviral Pathway
Michallet, M.-C., Meylan, E., Ermolaeva, M. A., Vazquez, J., Rebsamen, M., Curran, J., Poeck, H., Bscheider, M., Hartmann, G., König, M., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.013 · Cited by 306
An, H., Zhao, W., Hou, J., Zhang, Y., Xie, Y., Zheng, Y., Xu, H., Qian, C., Zhou, J., Yu, Y., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.10.014 · Cited by 245
Lin, R., Yang, L., Nakhaei, P., Sun, Q., Sharif-Askari, E., Julkunen, I., & Hiscott, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510326200 · Cited by 215
A20 Is a Negative Regulator of IFN Regulatory Factor 3 Signaling
Saitoh, T., Yamamoto, M., Miyagishi, M., Taira, K., Nakanishi, M., Fujita, T., Akira, S., Yamamoto, N., & Yamaoka, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1507 · Cited by 182
Sakamoto, H., Yasukawa, H., Masuhara, M., Tanimura, S., Sasaki, A., Yuge, K., Ohtsubo, M., Ohtsuka, A., Fujita, T., Ohta, T., et al. (1998) · Blood · doi:10.1182/blood.v92.5.1668 · Cited by 177
Self-citationSprouty2 and Sprouty4 are essential for embryonic morphogenesis and regulation of FGF signaling
Taniguchi, K., Ayada, T., Ichiyama, K., Kohno, R.-I., Yonemitsu, Y., Minami, Y., Kikuchi, A., Maehara, Y., & Yoshimura, A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.11.107 · Cited by 134
Self-citationRegulation of IκB Kinase-related Kinases and Antiviral Responses by Tumor Suppressor CYLD
Zhang, M., Wu, X., Lee, A. J., Jin, W., Chang, M., Wright, A., Imaizumi, T., & Sun, S.-C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801451200 · Cited by 132
Mashima, R., Saeki, K., Aki, D., Minoda, Y., Takaki, H., Sanada, T., Kobayashi, T., Aburatani, H., Yamanashi, Y., & Yoshimura, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508221200 · Cited by 66
Self-citation
Cited by
Immune Signaling by RIG-I-like Receptors
Loo, Y.-M., & Gale, M. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.003 · Cited by 1,875
Dynamic profiling of the protein life cycle in response to pathogens
Jovanovic, M., Rooney, M. S., Mertins, P., Przybylski, D., Chevrier, N., Satija, R., Rodriguez, E. H., Fields, A. P., Schwartz, S., Raychowdhury, R., et al. (2015) · Science · doi:10.1126/science.1259038 · Cited by 460
“3F) (34) is the main cause of a strong increase in its protein.”
BackgroundPaz, S., Vilasco, M., Werden, S. J., Arguello, M., Joseph-Pillai, D., Zhao, T., Nguyên, T. L.-A., Sun, Q., MEURS, E. F., Lin, R., et al. (2011) · Cell Research · doi:10.1038/cr.2011.2 · Cited by 168
Signatures of founder effects, admixture, and selection in the Ashkenazi Jewish population
Bray, S. M., Mulle, J. G., Dodd, A. F., Pulver, A. E., Wooding, S., & Warren, S. T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004381107 · Cited by 118
Regulation of RLR-mediated innate immune signaling – It is all about keeping the balance
Eisenächer, K., & Krug, A. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.01.011 · Cited by 136
“…et al. (2008) EYA4 IPS-1, NLRX1 Association with IPS-1 and NLRX1 Okabe et al. (2009) FLN29 IPS-1, TRAF3, TRAF6 Interaction with IPS-1, TRAF3 and TRAF6 Sanada et al. (2008) PLK1 IPS-1 Disruption of IPS-1-TRAF3 interaction Vitour et al. (2009) Targeting the stability of IPS-1 PSMA7 IPS-1…”
Background
Metadata
- Authors
- Sanada, T., Takaesu, G., Mashima, R., Yoshida, R., Kobayashi, T., & Yoshimura, A.
- Affiliations
- Kyushu University (JP)
- Institute of Medical Science, The University of Tokyo (JP)
- Corresponding author
- Yoshimura, Akihiko
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 283
- Issue
- 49
- Pages
- 33858-33864
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2662213
- OpenAlex
- W2067240517
- Cited by
- 66
- References
- 27
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 2 · 2022: 2 · 2021: 6 · 2020: 3 · 2019: 5 · 2018: 4 · 2017: 3 · 2016: 3 · 2015: 6 · 2014: 3 · 2013: 6 · 2012: 1
- FWCI
- 1.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4310 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- TLR4 signaling, IPS-1, TRAF6, TRAF3, TRIF, NF-κB activation, IRF3 activation, interferon-beta, septic shock, interferon-stimulated genes, negative regulation of innate immunity
- MeSH terms
- DEAD Box Protein 58, Roundabout Proteins, Animals, Gene Expression Regulation, Humans, Lipopolysaccharides, Membrane Proteins, Mice, Transgenic, Nerve Tissue Proteins, Receptors, Cell Surface, Receptors, Immunologic, Signal Transduction, NF-kappa B, Vesiculovirus, Intracellular Signaling Peptides and Proteins, Interferon Regulatory Factor-3, Toll-Like Receptor 4, Mice, DEAD-box RNA Helicases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.